Close Menu

NEW YORK – Molecular diagnostic firm PathoFinder announced Wednesday its SARS-CoV-2 detection kit has obtained the CE mark, allowing it to be marketed in the European Union and other countries recognizing the CE mark. 

The RealAccurate Quadruplex Corona-plus PCR kit detects SARS-CoV-2 from nasopharyngeal and oropharyngeal swabs within two hours. The test also detects Middle East Respiratory Syndrome.

The Maastricht, Netherlands-based company said it expects to be able to deliver "several thousands" of SARS-CoV-2 tests in the coming weeks.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Science reports that a new White House Office of Management and Budget memo rescinds previous ones that helped research institutions deal with pandemic-related closures.

Researchers report on a concerning strain of the H1N1 swine flu virus found among pigs in China, Agence France Presse reports.

The Associated Press reports that US officials are considering allowing pooled COVID-19 testing.

In Genome Research this week: Y chromosome gene expression analysis, de novo mutations rise with paternal age in rhesus macaques, and more.